Acrivon Therapeutics
ACRV
$5.80
Share price
-4.29%
Change (1 day)
-55.62%
Change (1 year)
Categories
Acrivon Therapeutics (ACRV) - Cash on Hand
Cash on Hand as of March 2024 : $0.10 B
According to Acrivon Therapeutics's latest financial reports the company has $0.10 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Acrivon Therapeutics - Cash on Hand chart (from 2021 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.12 B | 28.26% |
| 2021-12-31 | $99.6 M | 6192.04% |
| 2020-12-31 | $1.58 M |